Eric Mabery
Impact in
- Endocrine and Autonomic Systems top 10%
- Circadian rhythm and melatonin
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- HIV/AIDS drug development and treatment 6
-
- Hepatitis C virus research 6
- Co-authors
- David S. Schneider (2 shared papers)I‐hung Shih (7 shared papers)Richard L. Mackman (4 shared papers)Michal Hocek (4 shared papers)Peter Šilhár (2 shared papers)Ivan Votruba (3 shared papers)Michael D. Gordon (1 shared paper)Linh N Pham (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Hepatology (3 papers)Bioorganic & Medicinal Chemistry (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Journal of Innate Immunity (1 paper)
- Partner nations
- United StatesCzechiaItaly
In The Last Decade
Eric Mabery
17 papers receiving 467 citations
Peers
Comparison fields: 5 of 71
- Endocrine and Autonomic Systems 64
- Hepatology 70
- Aging 16
- Insect Science 69
- Infectious Diseases 80
Countries citing papers authored by Eric Mabery
This map shows the geographic impact of Eric Mabery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Mabery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Mabery more than expected).
Fields of papers citing papers by Eric Mabery
This network shows the impact of papers produced by Eric Mabery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Mabery. The network helps show where Eric Mabery may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Mabery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 87 | |
| 2 | 2015 | 61 | |
| 3 | 2007 | 49 | |
| 4 | 2006 | 42 | |
| 5 | 2009 | 38 | |
| 6 | 2017 | 38 | |
| 7 | 2010 | 36 | |
| 8 | 2002 | 27 | |
| 9 | 2007 | 22 | |
| 10 | 2009 | 18 | |
| 11 | 2007 | 16 | |
| 12 | Mechanistic characterization of GS-9190, a novel non-nucleoside inhibitor of HCV NS5B polymerase with potent antiviral activity and a unique mechanism of action | 2007 | 12 |
| 13 | 2014 | 10 | |
| 14 | 2011 | 8 | |
| 15 | GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants | 2007 | 8 |
| 16 | 2011 | 7 | |
| 17 | 2011 | 3 |
About Eric Mabery
Eric Mabery is a scholar working on Infectious Diseases, Hepatology, Molecular Biology, Epidemiology and Organic Chemistry, having authored 17 papers that have together received 482 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (3 papers), Circadian rhythm and melatonin (2 papers), Invertebrate Immune Response Mechanisms (2 papers), Neurobiology and Insect Physiology Research (2 papers), Biochemical and Molecular Research (2 papers) and Insect symbiosis and bacterial influences (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (64 citations), Hepatology (70 citations), Aging (16 citations), Insect Science (69 citations) and Infectious Diseases (80 citations). Eric Mabery has collaborated with scholars based in United States, Czechia and Italy. Frequent co-authors include David S. Schneider, I‐hung Shih, Richard L. Mackman, Michal Hocek, Peter Šilhár, Ivan Votruba, Michael D. Gordon, Linh N Pham, Mimi Shirasu‐Hiza and Stephanie M. Brandt. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Hepatology, Bioorganic & Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Innate Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.